Alex Bateman Wins 2010 Benjamin Franklin Award



By Kevin Davies

April 1, 2010 | The Bioinformatics Organization has named Alex Bateman, a senior investigator at the Wellcome Trust Sanger Institute in Cambridge, UK, as the winner of the 2010 Benjamin Franklin Award.

Bateman told Bio-IT World he was delighted to win the award. “I strongly believe that open biologically databases are essential to the development of science and technology. This award is only possible due to the tireless work of our biocurators who make the mass of sequence data understandable. Biocurators really are the unsung heroes of molecular biology.”

Bateman was selected from a strong group of finalists that included Don Gilbert (Indiana University), David Lipman (NCBI), John Quackenbush (Harvard School of Public Health), and G.P.S. Raghava (Institute of Microbial Technology). Bateman is the third scientist from the twin campuses of the Sanger Institute and European Bioinformatics Institute to win the award, following in the footsteps of Ewan Birney and Michael Ashburner. He will receive his award from bioinformatics.org president Jeff Bizzaro and give a free lecture on April 21 at the Bio-IT World Conference & Expo in Boston.

Since arriving at the Sanger in 1997, Bateman has established the freely available Pfam, Rfam and MEROPS databases, which aid in the classification of protein and RNA sequences to better understand their function and evolution. His work has incorporated Wikipedia annotation into Rfam, drawing on the support of the diverse Wikipedia community, which Bateman said has made “an enormous and lasting contribution to open knowledge.”

The Pfam database contains more than 12,000 entries and played a valuable role in the annotation of the human genome. In 2003 he founded the Rfam database of non-coding RNAs that provides annotation and models for hundreds of RNA families. Bateman has also served as executive editor for the open-access database issue of the journal Nucleic Acids Research, and helped initiate the RNA Families track at the journal RNA Biology, which requires a Wikipedia article for each published RNA family. He has been the executive editor for Bioinformatics since 2004, and since 2007, Bateman has been in charge of the PhD program at the Sanger Institute.

Bateman gave special credit to Sam Griffiths-Jones, Jen Daub and Paul Gardner for the
 Rfam@WikiPedia project and Rob Finn, Penny Coggill, Jaina Mistry, John Tate and Prasad Gunasekaran in the Pfam group.

Bateman also acknowledged the previous winners of the Benjamin Franklin Award, whom he called “a big influence during my scientific career and taught me the value of free software and free data.” Bateman has collaborated with a past Franklin Award winner, HHMI investigator Sean Eddy, using the HMMER software to identify novel protein domains.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .